Standpharm
Xiga 5mg Tablets 14s
60ml Drops
Rated 4.5 out of 5 (49)
Rs. 1,595
In Stock
Novartis
Empaa Tablets 25mg 28s
Rated 4.5 out of 5 (43)SKU HP-06744
A tablet containing Empagliflozin, indicated for Diabetes.
Rs. 2,135
60ml Drops
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Empaa Tablets 25mg 28s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 2,135
What it is used for: Diabetes.
Indications as listed by the manufacturer: Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance. Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.
How it works: Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.
Active ingredient: Empagliflozin.
Reported side effects: Very Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination. Uncommon : Volume depletion, dysuria and blood creatinine increased / glomerular filtration rate decreased. Rare : Diabetic ketoacidosis
Known drug interactions: Diuretics , thiazide and loop diuretics , SGLT2 inhibitors
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Monotherapy and add-on combination therapy - Adults : The recommended starting dose is 10mg empagliflozin once daily with or without food for monotherapy. The dose can be increased to 25mg once daily. The maximum daily dose is 25mg. When empagliflozin is used in combination with a sulphonylurea or with insulin, a lower dose of the sulphonylurea or insulin may be considered to reduce the risk of hypoglycemia . Children : Not Recommended . Always consult your doctor or pharmacist for dose adjustments.
Active ingredient: Empagliflozin. Labelled strength: 25mg.
- Empagliflozin is contraindicated in: • Patients with known hypersensitivity to empagliflozin or to any excipient of the product. • Severe renal impairment, end-stage renal disease or dialysis.
- Insulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin. Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.
- Empagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.
- Empagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised.
- Empagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Empaa Healthcare (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 543 verified ratings
- 5★100%
- 4★0%
- 3★0%
- 2★0%
- 1★0%
- Komal J.Verified Purchase4 Aug 2026Rated 5.0 out of 5
Been using this for a few months now. Ordering here is cheaper than my local shop and the packing is always careful.
- Bilal AhmedVerified Purchase26 Jul 2026Rated 5.0 out of 5
Been using this for a few months now. Ordering here is cheaper than my local shop and the packing is always careful.
- Mehwish A.9 Jul 2026Rated 5.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Shahid HussainVerified Purchase8 Jul 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Diabetes.
Indications as listed by the manufacturer: Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance. Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.
How it works: Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.
Active ingredient: Empagliflozin.
Reported side effects: Very Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination. Uncommon : Volume depletion, dysuria and blood creatinine increased / glomerular filtration rate decreased. Rare : Diabetic ketoacidosis
Known drug interactions: Diuretics , thiazide and loop diuretics , SGLT2 inhibitors
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Monotherapy and add-on combination therapy - Adults : The recommended starting dose is 10mg empagliflozin once daily with or without food for monotherapy. The dose can be increased to 25mg once daily. The maximum daily dose is 25mg. When empagliflozin is used in combination with a sulphonylurea or with insulin, a lower dose of the sulphonylurea or insulin may be considered to reduce the risk of hypoglycemia . Children : Not Recommended . Always consult your doctor or pharmacist for dose adjustments.
Active ingredient: Empagliflozin. Labelled strength: 25mg.
- Empagliflozin is contraindicated in: • Patients with known hypersensitivity to empagliflozin or to any excipient of the product. • Severe renal impairment, end-stage renal disease or dialysis.
- Insulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin. Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.
- Empagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.
- Empagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised.
- Empagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Empaa Healthcare (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 543 verified ratings
- 5★100%
- 4★0%
- 3★0%
- 2★0%
- 1★0%
- Komal J.Verified Purchase4 Aug 2026Rated 5.0 out of 5
Been using this for a few months now. Ordering here is cheaper than my local shop and the packing is always careful.
- Bilal AhmedVerified Purchase26 Jul 2026Rated 5.0 out of 5
Been using this for a few months now. Ordering here is cheaper than my local shop and the packing is always careful.
- Mehwish A.9 Jul 2026Rated 5.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Shahid HussainVerified Purchase8 Jul 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
NovartisEmpaa Tablets 25mg 28sRs. 2,135Rated 4.5 out of 5
Highnoon LabsGenthro 500mg Tablets 6sRs. 1,275Rated 4.5 out of 5
StandpharmAtenorm Tablets 50mg 14sRs. 975Rated 4.5 out of 5
Bundle total
Rs. 4,385Rs. 4,560
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
